In conversation with Fierce Biotech’s Chris Hayden, Austin Read, head of PPD™ CorEvitas™ Precision Medicine, Thermo Fisher ...

Triangle-based Continuous Precision Medicine developed a mobile app to track pain management and prescription medication ...

The genomic biomarkers market is experiencing rapid growth, driven by advancements in precision medicine, early disease ...

- Scientific Advisory Board brings together distinguished experts in neuroscience to support Denovo's CNS development programs, including the Phase 3-ready lead program, biomarker-guided DB104 ...

The Ibero-American Consortium gathers over 3000 DNA samples to drive precision strategies for rheumatoid arthritis and ...

We are in an age where medicine is no longer one-size-fits-all; personalised healthcare is changing the diagnosis and ...

Her Highness Sheikha Moza bint Nasser, Chairperson of Qatar Foundation for Education, Science and Community Development, ...

Rising brain tumor cases in India, with advanced imaging techniques and treatment options offering hope for better outcomes.

Tempus AI, Inc. (NASDAQ:TEM), a leader in artificial intelligence for healthcare, has announced the launch of Fuses, a ...

Panelists discuss how the future of polycythemia vera (PV) management will be shaped by advancements in targeted therapies, ...

In a report recently published in the American Journal of Health-System Pharmacy, the Ochsner Health system investigates the ...

Shares of Tempus AI ( TEM 14.71%) soared on Monday. The company's stock jumped 15% as of market close. The spike comes as the ...